AI Generated Image
Nearly 12 million Rohto eye drops recalled over sterility concerns
Fox Business • • business
Key Points:
- Nearly 12 million bottles of Rohto Cooling Eye Drops have been voluntarily recalled due to concerns over sterility, as they may contain harmful microorganisms, according to the FDA.
- The recall, classified as Class II, affects eight Rohto products with expiration dates from July 2025 to February 2029 and includes single and twin-pack configurations distributed nationwide.
- Consumers are advised to stop using the affected products immediately and either dispose of them or return them for a full refund, checking lot numbers and expiration dates against the FDA recall notice.
- The eye drops were manufactured in Vietnam by Rohto-Mentholatum and distributed by The Mentholatum Company in New York.
- This recall follows other recent FDA Class II recalls, including over 2.5 million bottles of a prescription steroid eye medication and certain lots of generic cetirizine tablets due to contamination concerns.
